secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001437749-26-012764
Event type: regulatory
Sentiment:  positive
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia announces PMDA acceptance of CardiAMP data for ischemic heart failure clearance in Japan
--------------------------------------------------------------------------------

- PMDA determined CardiAMP safety/efficacy data likely sufficient for market clearance in ischemic heart failure.
- Alignment reached on acceptability of US foreign clinical data, indications for use, and introduction approach.
- Company will await formal minutes from PMDA for detailed feedback and filing timeline.
- CEO Dr. Peter Altman states company on track for first minimally invasive biologic therapy approved in Japan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926012764/0001437749-26-012764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926012764/bcda20260416_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer